The Ministry of Health has withdrawn from the market products containing fenfluramine and dexfenfluramine because of reports of cardiotoxicity associated with their use.
[See also Information Exchange Alert No. 63 dated 9 September 1997 and Pharmaceuticals Newsletter Nos. 1&2, January & February 1998 and Nos. 9&10, September & October 1997]
Reference: Communication from the WHO Regional Office for the Eastern Mediterranean enclosing a notification from the Ministry of Health, Saudi Arabia, 20 June 1999.